The Latest in Hepatitis

Infectious Disease Practitioner

Sofosbuvir/R yields benefits in compassionate use HCV program

November 17, 2015

Hepatitis

Infectious Disease Practitioner

VIDEO: Longer HCV therapy worked even after short-term failures

November 17, 2015

Hepatitis

Infectious Disease Practitioner

Multitargeted drug combination promising when new HCV antivirals fail

November 17, 2015

Hepatitis

Infectious Disease Practitioner

Regimen effective in genotype 3 HCV despite advanced cirrhosis

November 17, 2015

Hepatitis

Infectious Disease Practitioner

VIDEO: Antigen test could simplify HCV screening

November 17, 2015

Infectious Disease Practitioner

VIDEO: Inappropriate hepatitis A, B tests may be widespread in hospitals

November 17, 2015

Hepatitis

Infectious Disease Practitioner

ASTRAL-1: High SVR12 with sofosbuvir/velpatasvir combo for HCV

November 17, 2015

Hepatitis

Infectious Disease Practitioner

High SVR achieved in decompensated HCV patients with 12-week therapy

November 17, 2015

Hepatitis

Infectious Disease Practitioner

New direct-acting antivirals for HCV perform well in real world

November 17, 2015

Hepatitis

Infectious Disease Practitioner

VIDEO: Ledipasvir/sofosbuvir highly effective in treatment-naive HCV GT1

November 16, 2015

Hepatitis

Infectious Disease Practitioner

Eight-week, three-drug regimen produces SVR over 90% in HCV

November 14, 2015

Hepatitis

Infectious Disease Practitioner

Sofosbuvir plus velpatasvir effective at treating HCV genotype 1 and 3 patients

November 10, 2015

Hepatitis

Infectious Disease Practitioner

Sofosbuvir-velpatasvir combo effective in treatment-naive HCV patients*

November 10, 2015

Hepatitis

Infectious Disease Practitioner

FDA warns of serious liver injury from HCV drugs Viekira Pak and Technivie

October 22, 2015

Hepatitis

Infectious Disease Practitioner

IDWeek: Despite better drugs, HCV deaths keep rising

October 19, 2015

Hepatitis